Classifying Breast Cancer Metastasis Based on Imaging of Tumor Primary and Tumor Biology

The molecular classification of breast cancer has allowed for a better understanding of both prognosis and treatment of breast cancer. Imaging of the different molecular subtypes has revealed that biologically different tumors often exhibit typical features in mammography, ultrasound, and MRI. Here, we introduce the molecular classification of breast cancer and review the typical imaging features of each subtype, examining the predictive value of imaging with respect to distant metastases.

• Publication year

  2023

• Venue

  Diagnostics

• Publication date

  2023-01-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/diagnostics13030437PMID 36766541PMCID 9914718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review

  2022cited by this paper
• Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

  2022influential reference
• Predicting Molecular Subtypes of Breast Cancer with Mammography and Ultrasound Findings: Introduction of Sono-Mammometry Score

  2021influential reference
• Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer

  2021cited by this paper
• Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients

  2021cited by this paper
• "Association of mammographic features with molecular breast tumor profiles".

  2021cited by this paper
• Magnetic Resonance Imaging Phenotypes of Breast Cancer Molecular Subtypes: A Systematic Review.

  2021cited by this paper
• Breast Cancer Treatments: Updates and New Challenges

  2021cited by this paper
• Breast cancer

  2021cited by this paper
• Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3

  2021cited by this paper
• Diffusion-Weighted Imaging of Different Breast Cancer Molecular Subtypes: A Systematic Review and Meta-Analysis

  2020cited by this paper
• Imaging diagnosis of metastatic breast cancer

  2020influential reference
• Histological and molecular classification of breast cancer: what do we know?

  2020influential reference
• Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019.

  2019cited by this paper
• The Relationship Between MRI Findings and Molecular Subtypes in Women With Breast Cancer.

  2019cited by this paper
• Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer

  2019cited by this paper
• Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings

  2018influential reference
• Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

  2018cited by this paper
• Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer

  2018cited by this paper
• Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification

  2018cited by this paper
• Relationships Between MRI Breast Imaging‐Reporting and Data System (BI‐RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype

  2017cited by this paper
• 18F–FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer

  2017cited by this paper
• Molecular imaging using PET and SPECT for identification of breast cancer subtypes

  2016cited by this paper
• Breast cancer molecular subtype classifier that incorporates MRI features

  2016cited by this paper
• Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates: Surgical Results from CALGB 40603 (Alliance)

  2016cited by this paper
• Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

  2016cited by this paper
• Ki-67 as a prognostic marker according to breast cancer molecular subtype

  2016cited by this paper
• Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?

  2016cited by this paper
• Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer

  2016cited by this paper
• Metastatic patterns of breast cancer subtypes: what radiologists should know in the era of personalized cancer medicine.

  2015cited by this paper
• Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.

  2015influential reference
• Can breast cancer molecular subtype help to select patients for preoperative MR imaging?

  2015cited by this paper
• Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms

  2015cited by this paper
• Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).

  2015cited by this paper
• Imaging Features of HER2 Overexpression in Breast Cancer: A Systematic Review and Meta-analysis

  2014influential reference
• Luminal B breast cancer: molecular characterization, clinical management, and future perspectives.

  2014cited by this paper
• Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics

  2014cited by this paper
• Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.

  2013cited by this paper
• The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer

  2013cited by this paper
• Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

  2013cited by this paper
• The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer

  2013cited by this paper
• Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT

  2013cited by this paper
• 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer

  2013cited by this paper
• Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes

  2012cited by this paper
• Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.

  2011cited by this paper
• Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

  2010cited by this paper
• Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer

  2009cited by this paper
• Imaging of HER-2 overexpression in tumors for guiding therapy.

  2008cited by this paper
• HER2/neu role in breast cancer: from a prognostic foe to a predictive friend

  2007cited by this paper
• Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

  2006cited by this paper
• [Breast cancer].

  2006influential reference
• Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain

  1998cited by this paper

• Stratifying Breast Lesion Risk Using BI-RADS: A Correlative Study of Imaging and Histopathology

  2025cites this paper
• Therapeutic potential of phytochemicals against breast cancer: current status and future perspectives

  2025cites this paper
• Naturally Occurring Phytochemicals to Target Breast Cancer Cell Signaling

  2023cites this paper